If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccesso Technology Group Regulatory News (ACSO)

Share Price Information for Accesso Technology Group (ACSO)

Share Price is delayed by 15 minutes
Get Live Data
320.50    -2.50 (-0.77%)
Bid:
322.50
Ask:
326.50
Spread: 4.00 (1.24%)
Market Cap: £103.82m
ACSO Live PriceLast checked at - London Stock Exchange

Intraday Accesso Technology Group Share Chart

Director/PDMR Shareholding

12 Jun 2020 13:02

RNS Number : 8518P
Accesso Technology Group PLC
12 June 2020
 

 

 

12 June 2020

accesso® Technology Group plc

(the "Company")

Director / PDMR Dealing Notification

 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Persons Closely Associated with them

1.

Details of PDMR

a)

Name

1. Fern MacDonald

2. David Gammon

3. Karen Slatford

4. Andy Malpass

5. Bill Russell

2.

Reason for the notification

a)

Position / status

1. Chief Financial Officer

2. Non-Executive Director

3. Non-Executive Director

4. Non-Executive Director

5. Non-Executive Director

b)

Initial notification / amendment

Initial notification in each case

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

ACCESSO TECHNOLOGY GROUP PLC

b)

LEI

213800VY7MXUO7STIN73

4.

Details of the transaction(s)

a)

Description of the financial instrument

Identification Code

Ordinary Shares of accesso Technology Group plc (the 'Company') of 1 pence each 

 

ISIN: GB0001771426

 

b)

Nature of the transaction

The Company announced on 9 June 2020 that it raised gross proceeds of approximately £39.1 million through a Placing, Subscription and Open Offer. 13,481,744 new Ordinary Shares were admitted to trading on AIM on 10 June 2020. The Company's issued ordinary share capital now comprises 41,186,708 Ordinary Shares.

 

Director

Interest in shares prior to acquisition

Number of shares acquired

Total shares held beneficially on admission

% of issued share capital held

Fern

MacDonald

 

5,500

6,445

11,945

0.03%

David Gammon

 

48,000

38,483

86,483

0.21%

Karen Slatford

 

11,835

4,714

16,549

0.04%

 

Andy Malpass

 

4,352

1,062

5,414

0.01%

Bill Russell

 

30,000

2,307

32,307

0.08%

c)

Currency

GBP - British Pound

d)

Price(s) and volume(s)

Price(s)

Volume(s)

1. 290 pence

6,445

2. 290 pence

38,483

3. 290 pence

4,714

4. 290 pence

1,062

5. 290 pence

2,307

e)

Aggregated information

 

Aggregated volume

 

Price

 

 

53,011 shares

 

290 pence

 

f)

Date of the transaction

10 June 2020

g)

Place of the transaction

London Stock Exchange

 

 

For further information, please contact:

accesso Technology Group plc

+44 (0)118 934 7400

Steve Brown, Chief Executive Officer

Fern MacDonald, Chief Financial Officer

Numis Securities Limited (Nominated Adviser and Sole Broker)

+44 (0)20 7260 1000

Simon Willis, Mark Lander, Hugo Rubinstein

FTI Consulting, LLP (Financial Public Relations)

+44 (0)20 3727 1000

Matt Dixon, Adam Davidson, Chris Birt

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFIFRIIFLII
Date   Source Headline
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
15th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20257:00 amRNSTransaction in Own Shares
12th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares
7th May 20251:00 pmRNS-Raccesso Acquires Technology of 1RISK
7th May 20257:00 amRNSTransaction in Own Shares
2nd May 20257:00 amRNSTransaction in Own Shares
1st May 20257:00 amRNSTotal Voting Rights
1st May 20257:00 amRNSTransaction in Own Shares
30th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 202511:17 amRNSAnnual Report and Notice of AGM
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:01 amRNSAdditional Listing
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:01 amRNSCommencement of Share Repurchase Programme
15th Apr 20257:00 amRNSFinal Results
9th Apr 20257:00 amRNS-Raccesso Expands with Strategic Win in Middle East
21st Mar 20257:00 amRNSNotice of Results
18th Mar 20257:00 amRNS-RCOO Appointment
28th Jan 20257:00 amRNSTrading Statement
13th Dec 20247:00 amRNSBlock Listing Return
2nd Dec 20247:00 amRNSTotal Voting Rights
18th Nov 20245:37 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 20247:01 amRNSTotal Voting Rights
1st Nov 20247:00 amRNSTransaction in Own Shares
31st Oct 20247:00 amRNSTransaction in Own Shares
30th Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
28th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTransaction in Own Shares
23rd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSTransaction in Own Shares
18th Oct 20247:00 amRNSTransaction in Own Shares
17th Oct 20247:00 amRNSAdditional Listing
16th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.